The Global Vaccine Tracker Dashboard is a cutting-edge, real-time resource dedicated to monitoring the global landscape of vaccine development. With a focus on providing comprehensive, up-to-the-minute data, the dashboard tracks over 55 major vaccine programs from their preclinical stages through to final FDA approval. This powerful tool synthesizes complex information, including data from over 400… Read More »
The Dengue Vaccine Clinical Trials Tracker offers a consolidated, real-time view of global efforts to develop safe, effective, and programmatically viable vaccines across all four dengue serotypes. It documents more than a dozen active clinical trials and provides clarity on the performance of the two WHO-prequalified vaccines. Dengvaxia, the first licensed vaccine, remains restricted to… Read More »
The Diabetes Vaccine & Immunotherapy Clinical Trials Tracker is a comprehensive real-time dashboard monitoring breakthrough prevention and treatment strategies for Type 1 diabetes. This platform tracks over 20 active clinical trials, including the landmark FDA-approved teplizumab (Tzield®)—the first disease-modifying therapy that delays T1D onset by approximately 2 years in high-risk individuals. The tracker covers revolutionary… Read More »
The Cancer Vaccine Clinical Trials Tracker provides an organized, real-time overview of more than 25 active therapeutic and prophylactic cancer vaccine trials across global registries. It highlights major platforms including mRNA, peptide-based, dendritic cell, and viral vector vaccines designed for melanoma, pancreatic cancer, breast cancer, lung cancer, and other malignancies. By integrating data from multiple… Read More »
The Malaria Vaccine Clinical Trials Tracker functions as a consolidated and continuously updated platform that documents global progress in vaccine development against a long-standing public health threat. By integrating data from major international trial registries and presenting information through a responsive, analytically rich interface, the dashboard offers clear insight into ongoing research efforts, geographic distribution,… Read More »
Despite 35 years of intensive research since the discovery of hepatitis C virus in 1989, the world still lacks a preventive vaccine—a stark contrast to the rapid development seen with COVID-19 vaccines. Our new Hepatitis C Vaccine Development Dashboard reveals the sobering reality: zero active clinical trials, one failed Phase 2 study, and only a… Read More »
After 100 years with only one TB vaccine, four promising candidates are now in advanced clinical trials—and one just completed enrollment ahead of schedule. Our interactive dashboard lets you track each candidate’s progress in real-time, from Gates Medical Research Institute’s $550M M72/AS01E trial to IAVI’s innovative MTBVAC vaccine derived from human TB strains. With 10.7… Read More »
HPV Vaccine Campaign in Pakistan 2025: Benefits, Fears, and Conspiracy Theories Explored The HPV vaccination campaign launched in Pakistan in September 2025 marks a significant public health initiative aimed at protecting young girls from cervical cancer. “One Jab Will Do the Job” Supported by organizations like Gavi, WHO, and UNICEF, the program targets girls aged… Read More »
The Evolving Landscape of Cancer Vaccines Cancer vaccines aim to harness the body’s natural immune defenses to fight tumor growth and prevent the development of cancer. Once considered a promising but unproven concept, cancer vaccines have advanced significantly in recent decades and are now an important part of cancer immunotherapy. Here is an overview of… Read More »
Vaccine hesitancy is a growing concern in the US, not only for COVID-19 but also for pet vaccinations. Canine Vaccine Hesitancy (CVH) is defined as “dog owners’ skepticism about the necessity, safety, and efficacy of vaccines”[4]. Nearly half of dog owners in the US are hesitant to vaccinate their pets, with beliefs that vaccinations are… Read More »